| 4.35 Delayed Data As of Sep 20 |  -0.16 / -3.55%Today’s Change | 1.56 Today|||52-Week Range 7.25 | +132.62% Year-to-Date |
| Previous close | 4.51 |
| Today’s open | 4.51 |
| Day’s range | 4.23 - 4.55 |
| Volume | 4,546,006 |
| Average volume (3 months) | 1,928,001 |
| Market cap | $767.3M |
| Earnings growth (last year) | +7.81% |
| Earnings growth (this year) | -136.87% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -97.71% |
| P/E ratio | 4.1 |
| Price/Sales | 1,838.09 |
| Price/Book | 8.88 |
| Today’s change | Today’s % change | |
|---|---|---|
| RCKTRocket Pharmaceutica... | +0.80 | +6.13% |
| NTLAIntellia Therapeutic... | -0.06 | -0.42% |
| CRTXCortexyme Inc | +2.99 | +12.46% |
| URGNUrogen Pharma Ltd | -0.65 | -1.83% |
| Next reporting date | November 4, 2019 |
| EPS forecast (this quarter) | -$0.09 |
| Annual revenue (last year) | $146.0K |
| Annual profit (last year) | -$53.1M |
| Net profit margin | -36,381.51% |
Sector Health Technology |
Industry Biotechnology |
Chief Executive Officer & Director Laurence James Neil Cooper |
President David M. Mauney |
Corporate headquarters Boston, Massachusetts |
